NEW YORK (GenomeWeb News) – Sequenom filed a prospectus today with the US Securities and Exchange Commission to sell 5.5 million shares of common stock through the open market.
 
The San Diego-based firm said that it expects to realize net proceeds of around $73.4 million, assuming an offering price of $14.25 per share, which was its closing price on the Nasdaq on Friday.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.